Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'

AIDS. 2007 Mar 30;21(6):777-8. doi: 10.1097/QAD.0b013e3280b07774.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Drug Therapy, Combination
  • HIV Infections / complications*
  • Hepatitis B / drug therapy*
  • Humans
  • Lamivudine / therapeutic use*
  • Organophosphonates / therapeutic use*
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Tenofovir
  • Treatment Failure

Substances

  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Tenofovir
  • Adenine